{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:46:16Z","timestamp":1787507176991,"version":"build-2736575974"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.vph.2021.106951","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T20:41:39Z","timestamp":1640032899000},"page":"106951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The close link between brain vascular pathological conditions and neurodegenerative diseases: Focus on some examples and potential treatments"],"prefix":"10.1016","volume":"142","author":[{"given":"Giuseppe","family":"Schir\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela Rita","family":"Balistreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vph.2021.106951_bb0005","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.arr.2010.08.006","article-title":"Ageing and neurodegenerative diseases","volume":"9","author":"Hung","year":"2010","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.vph.2021.106951_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12264-018-0326-3","article-title":"Brain banking for research into neurodegenerative disorders and ageing","volume":"35","author":"Shepherd","year":"2019","journal-title":"Neurosci. Bull."},{"issue":"5","key":"10.1016\/j.vph.2021.106951_bb0015","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbadis.2015.12.023","article-title":"Vascular contributions to cognitive impairment, clinical Alzheimer\u2019s disease, and dementia in older persons","volume":"1862","author":"Kapasi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.vph.2021.106951_bb0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/STROKEAHA.117.016995","article-title":"Rodent models of cerebral microinfarct and microhemorrhage","volume":"49","author":"Shih","year":"2018","journal-title":"Stroke"},{"issue":"Pt B","key":"10.1016\/j.vph.2021.106951_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2017.12.030","article-title":"The pathology and pathophysiology of vascular dementia","volume":"134","author":"Kalaria","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.vph.2021.106951_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.arr.2018.06.002","article-title":"Cerebral small vessel disease and the risk of Alzheimer\u2019s disease: a systematic review","volume":"47","author":"Liu","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2021.106951_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100857","article-title":"Blood-brain barrier integrity in the pathogenesis of Alzheimer\u2019s disease","volume":"59","author":"Huang","year":"2020","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.vph.2021.106951_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101483","article-title":"Interactions between glial cells and the blood-brain barrier and their role in Alzheimer\u2019s disease","volume":"72","author":"Zhao","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2021.106951_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111469","article-title":"Vascular ageing and the related complications in the brain: new insights on related mechanisms and their translational applications","volume":"196","author":"Balistreri","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.vph.2021.106951_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainresbull.2019.02.005","article-title":"Cumulative multiple early life hits- a potent threat leading to neurological disorders","volume":"147","author":"Sarkar","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.vph.2021.106951_bb0055","doi-asserted-by":"crossref","first-page":"8834645","DOI":"10.1155\/2021\/8834645","article-title":"Molecular factors mediating neural cell plasticity changes in dementia brain diseases","volume":"2021","author":"Kozubski","year":"2021","journal-title":"Neural Plast."},{"issue":"12","key":"10.1016\/j.vph.2021.106951_bb0060","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/ijms20123022","article-title":"The role of endothelial dysfunction in peripheral blood nerve barrier: molecular mechanisms and pathophysiological implications","volume":"20","author":"Maiuolo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2021.106951_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.732820","article-title":"The \u201cneuro-glial-vascular\u201d unit: the role of glia in neurovascular unit formation and dysfunction","volume":"9","author":"Kugler","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"6","key":"10.1016\/j.vph.2021.106951_bb0070","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1134\/S0006297921060122","article-title":"Blood-brain barrier breakdown in stress and neurodegeneration: biochemical mechanisms and new models for translational research","volume":"86","author":"Salmina","year":"2021","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.vph.2021.106951_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.arr.2016.09.006","article-title":"Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect","volume":"34","author":"Cai","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2021.106951_bb0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fnins.2020.00334","article-title":"Neurovascular unit dysfunction and neurodegenerative disorders","volume":"14","author":"Yu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.vph.2021.106951_bb0085","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3390\/ijms22042022","article-title":"The neurovascular unit dysfunction in Alzheimer\u2019s disease","volume":"22","author":"Soto-Rojas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10654-020-00696-3","article-title":"Design and overview of the origins of Alzheimer\u2019s disease across the life course (ORACLE) study","volume":"36","author":"Lamballais","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.vph.2021.106951_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100918","article-title":"Developmental programming of adult haematopoiesis system","volume":"54","author":"Balistreri","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2021.106951_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111461","article-title":"The close link between the fetal programming imprinting and neurodegeneration in adulthood: the key role of \u201chemogenic endothelium\u201d programming","volume":"195","author":"Allegra","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.vph.2021.106951_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/164_2020_404","article-title":"Structure and function of the Blood-Brain Barrier (BBB)","author":"Benz","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.vph.2021.106951_bb0110","doi-asserted-by":"crossref","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","article-title":"Structure of the blood-brain barrier and its role in the transport of amino acids","volume":"136","author":"Hawkins","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.vph.2021.106951_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-015-0029-9","article-title":"Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment","volume":"12","author":"Mina","year":"2015","journal-title":"Immun. Ageing"},{"issue":"2","key":"10.1016\/j.vph.2021.106951_bb0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.vph.2021.106951_bb0125","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ajpath.2021.07.003","article-title":"Interplay between brain Pericytes and endothelial cells in dementia","volume":"191","author":"Procter","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.vph.2021.106951_bb0130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3390\/diagnostics11091525","article-title":"Blood-based biomarkers of Neuroinflammation in Alzheimer\u2019s disease: a central role for periphery?","volume":"11","author":"Angiulli","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.vph.2021.106951_bb0135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","article-title":"Identification of early pericyte loss and vascular amyloidosis in Alzheimer\u2019s disease retina","volume":"139","author":"Shi","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.vph.2021.106951_bb0140","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/iub.2510","article-title":"Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage","volume":"73","author":"Pascual","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.vph.2021.106951_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.633610","article-title":"The role of NF-\u03baB triggered inflammation in cerebral ischemia","volume":"15","author":"Jover-Mengual","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.vph.2021.106951_bb0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease","volume":"17","author":"Ju","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.vph.2021.106951_bb0160","doi-asserted-by":"crossref","first-page":"766","DOI":"10.5603\/FM.a2021.0109","article-title":"Neuroglia - development and role in physiological and pathophysiological processes","volume":"80","author":"Cichorek","year":"2021","journal-title":"Folia Morphol (Warsz)"},{"key":"10.1016\/j.vph.2021.106951_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.653334","article-title":"Role of neuron and glia in Alzheimer\u2019s disease and associated vascular dysfunction","volume":"13","author":"Bandyopadhyay","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"17","key":"10.1016\/j.vph.2021.106951_bb0170","doi-asserted-by":"crossref","first-page":"21791","DOI":"10.18632\/aging.203482","article-title":"Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer\u2019s disease: an adrenergic approach","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.vph.2021.106951_bb0175","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","article-title":"Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease","volume":"140","author":"Korte","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.vph.2021.106951_bb0185","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/jnc.12334","article-title":"Endothelial nitric oxide deficiency promotes Alzheimer\u2019s disease pathology","volume":"127","author":"Austin","year":"2013","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-019-0326-4","article-title":"Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade","volume":"14","author":"Acquarone","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.vph.2021.106951_bb0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bpa.12331","article-title":"Pathophysiology of hypoperfusion of the precuneus in early Alzheimer\u2019s disease","volume":"26","author":"Miners","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.vph.2021.106951_bb0200","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/NDT.S203103","article-title":"What are the links between hypoxia and Alzheimer\u2019s disease?","volume":"15","author":"Lall","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.vph.2021.106951_bb0205","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/0008-5472.CAN-07-3217","article-title":"Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth","volume":"68","author":"Ebos John","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0210","doi-asserted-by":"crossref","first-page":"17713","DOI":"10.1038\/s41598-017-18042-1","article-title":"VEGFR2 alteration in Alzheimer\u2019s disease","volume":"7","author":"Cho","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2021.106951_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2019.03.002","article-title":"Novel function of VEGF-B as an antioxidant and therapeutic implications","volume":"143","author":"Chen","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.vph.2021.106951_bb0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","article-title":"Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"17","author":"Niebroj-Dobosz","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"16","key":"10.1016\/j.vph.2021.106951_bb0225","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1097\/00001756-200011090-00003","article-title":"Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis","volume":"11","author":"Beuche","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.vph.2021.106951_bb0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","article-title":"Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat","volume":"1301","author":"Nicaise","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.vph.2021.106951_bb0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1401595111","article-title":"Blood\u2013spinal cord barrier disruption contributes to early motor neuron degeneration in ALS-model mice","author":"Winkler","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2021.106951_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001205","article-title":"Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS","volume":"2","author":"Garbuzova-Davis","year":"2007","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vph.2021.106951_bb0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12017-020-08607-1","article-title":"Cell-free extracellular vesicles derived from human bone marrow endothelial progenitor cells as potential therapeutics for microvascular endothelium restoration in ALS","volume":"22","author":"Garbuzova-Davis","year":"2020","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.vph.2021.106951_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1742-2094-8-47","article-title":"Vascular endothelial growth factor-a (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients","volume":"8","author":"Gupta","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.vph.2021.106951_bb0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-328X(03)00025-1","article-title":"VEGF-induced activation of the PI3-K\/Akt pathway reduces mutant SOD1-mediated motor neuron cell death","volume":"111","author":"Li","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"30","key":"10.1016\/j.vph.2021.106951_bb0260","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1523\/JNEUROSCI.1877-07.2007","article-title":"Mutant Cu\/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression","volume":"27","author":"Lu","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.vph.2021.106951_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.636653","article-title":"Brain ischemia as a prelude to Alzheimer\u2019s disease","volume":"13","author":"Pluta","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.vph.2021.106951_bb0270","series-title":"Alzheimer\u2019s Disease [Internet]","article-title":"Common proteomic and genomic contribution to ischemic brain damage and Alzheimer\u2019s disease","author":"Pluta","year":"2019"},{"issue":"18","key":"10.1016\/j.vph.2021.106951_bb0275","doi-asserted-by":"crossref","first-page":"9689","DOI":"10.3390\/ijms22189689","article-title":"On the common journey of neural cells through ischemic brain injury and Alzheimer\u2019s disease","volume":"22","author":"Kriska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2021.106951_bb0280","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2021.0216","article-title":"Alzheimer\u2019s disease-related dementias summit 2019: national research priorities for the investigation of traumatic brain injury as a risk factor for Alzheimer\u2019s disease and related dementias","author":"Dams-O\u2019Connor","year":"2021","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.vph.2021.106951_bb0285","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2174\/1567205013666161201200429","article-title":"Cerebral microinfarcts and dementia: a systematic review and metaanalysis","volume":"14","author":"Cao","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"7","key":"10.1016\/j.vph.2021.106951_bb0290","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.vph.2021.106951_bb0295","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1177\/0963689718795148","article-title":"Cerebral small vessel disease","volume":"27","author":"Li","year":"2018","journal-title":"Cell Transplant."},{"issue":"7","key":"10.1016\/j.vph.2021.106951_bb0300","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-018-0014-y","article-title":"Cerebral small vessel disease: from a focal to a global perspective","volume":"14","author":"Ter Telgte","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.vph.2021.106951_bb0305","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jnnp-2019-321767","article-title":"Structural network changes in cerebral small vessel disease","volume":"91","author":"Tuladhar","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.vph.2021.106951_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.735036","article-title":"The relationship of APOE \u03b54, race, and sex on the age of onset and risk of dementia","volume":"12","author":"Powell","year":"2021","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","article-title":"Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies","volume":"118","author":"Revesz","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.vph.2021.106951_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.749026","article-title":"From neurodevelopmental to neurodegenerative disorders: the vascular continuum","volume":"13","author":"Ouellette","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.vph.2021.106951_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.727590","article-title":"Neurovascular alterations in vascular dementia: emphasis on risk factors","volume":"13","author":"Lecordier","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.vph.2021.106951_bb0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/rej.2017.1946","article-title":"Stem cells and other emerging agents as innovative \u201cdrugs\u201d in neurodegenerative diseases: benefits and limitations","volume":"21","author":"Nasello","year":"2018","journal-title":"Rejuvenation Res."},{"issue":"4","key":"10.1016\/j.vph.2021.106951_bb0335","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s11033-020-05353-2","article-title":"Stem cell therapy: old challenges and new solutions","volume":"47","author":"Balistreri","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"8","key":"10.1016\/j.vph.2021.106951_bb0340","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4252\/wjsc.v13.i8.1072","article-title":"Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation","volume":"13","author":"Skok","year":"2021","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.vph.2021.106951_bb0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fphar.2019.00355","article-title":"Intravenously injected mesenchymal stem cells penetrate the brain and treat inflammation-induced brain damage and memory impairment in mice","volume":"10","author":"Lykhmus","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.vph.2021.106951_bb0350","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","article-title":"Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson\u2019s disease","volume":"216","author":"Chao","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.vph.2021.106951_bb0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2016.11.009","article-title":"Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer\u2019s disease","volume":"51","author":"Harach","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.vph.2021.106951_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00030","article-title":"Therapeutic effects of the transplantation of vegf overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of alzheimer\u2019s disease","volume":"6","author":"Garcia","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.vph.2021.106951_bb0365","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13287-015-0180-4","article-title":"Mesenchymal stem cells stabilize the bloodbrain barrier through regulation of astrocytes","volume":"6","author":"Park","year":"2015","journal-title":"Stem Cell Res. Ther."},{"issue":"11","key":"10.1016\/j.vph.2021.106951_bb0370","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1007\/s00415-020-10138-5","article-title":"Mesenchymal stem cell therapy for ischemic stroke: a look into treatment mechanism and therapeutic potential","volume":"268","author":"Li","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.vph.2021.106951_bb0375","article-title":"Psychedelic-inspired approaches for treating neurodegenerative disorders","author":"Saeger","year":"2021","journal-title":"J. Neurochem."},{"issue":"19","key":"10.1016\/j.vph.2021.106951_bb0380","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.3390\/ijms221910707","article-title":"Unusual bioactive compounds with antioxidant properties in adjuvant therapy supporting cognition impairment in age-related neurodegenerative disorders","volume":"22","author":"Cichon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.vph.2021.106951_bb0385","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/antiox10071044","article-title":"Olive polyphenols: antioxidant and anti-inflammatory properties","volume":"10","author":"Bucciantini","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.vph.2021.106951_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113655","article-title":"Silyl resveratrol derivatives as potential therapeutic agents for neurodegenerative and neurological diseases","volume":"223","author":"Belmonte-Reche","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.vph.2021.106951_bb0395","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s12031-014-0441-1","article-title":"Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9\/TIMP-1 balance after cerebral ischemia reperfusion in rats","volume":"55","author":"Wei","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.vph.2021.106951_bb0400","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/nyas.13431","article-title":"Resveratrol for Alzheimer\u2019s disease","volume":"1403","author":"Sawda","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.apsb.2014.12.003","article-title":"Quercetin protects human brain microvascular endothelial cells from fibrillar beta-amyloid1-40-induced toxicity","volume":"5","author":"Li","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.vph.2021.106951_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112236","article-title":"Antioxidant properties of flavonoid metal complexes and their potential inclusion in the development of novel strategies for the treatment against neurodegenerative diseases","volume":"143","author":"Rodr\u00edguez-Arce","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.vph.2021.106951_bb0415","first-page":"1","article-title":"Physical exercise protects against endothelial dysfunction in cardiovascular and metabolic diseases","author":"Gao","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"6","key":"10.1016\/j.vph.2021.106951_bb0420","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/biom11060790","article-title":"Mediterranean diet and neurodegenerative diseases: the neglected role of nutrition in the modulation of the endocannabinoid system","volume":"11","author":"Armeli","year":"2021","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.vph.2021.106951_bb0425","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s13238-021-00858-3","article-title":"Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model","volume":"12","author":"Xu","year":"2021","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.vph.2021.106951_bb0430","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12774","article-title":"Melatonin ameliorates cognitive deficits through improving mitophagy in a mouse model of Alzheimer\u2019s disease","volume":"71","author":"Chen","year":"2021","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.vph.2021.106951_bb0435","doi-asserted-by":"crossref","first-page":"3705389","DOI":"10.1155\/2018\/3705389","article-title":"Anti-Inflamm-ageing and\/or anti-age-related disease emerging treatments: a historical alchemy or revolutionary effective procedures?","volume":"2018","author":"Balistreri","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"23","key":"10.1016\/j.vph.2021.106951_bb0440","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.3390\/ijms20236015","article-title":"On the road to accurate biomarkers for cardiometabolic diseases by integrating precision and gender medicine approaches","volume":"20","author":"Scola","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.vph.2021.106951_bb0445","doi-asserted-by":"crossref","first-page":"9098","DOI":"10.3390\/ijms22169098","article-title":"GSK-3\u03b2, FYN, and DYRK1A: master regulators in neurodegenerative pathways","volume":"22","author":"Demuro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.vph.2021.106951_bb0450","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12640-020-00270-5","article-title":"Sepsis and cerebral dysfunction: BBB damage, neuroinflammation, oxidative stress, apoptosis and autophagy as key mediators and the potential therapeutic approaches","volume":"39","author":"Gu","year":"2021","journal-title":"Neurotox. Res."},{"issue":"7","key":"10.1016\/j.vph.2021.106951_bb0455","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s10072-021-05234-x","article-title":"Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment","volume":"42","author":"Asefy","year":"2021","journal-title":"Neurol. Sci."},{"issue":"15","key":"10.1016\/j.vph.2021.106951_bb0460","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1039\/D0BM00809E","article-title":"Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases","volume":"8","author":"Masoudi Asil","year":"2020","journal-title":"Biomater Sci."},{"issue":"1","key":"10.1016\/j.vph.2021.106951_bb0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871527319666200916121515","article-title":"Nanotechnology: its application in treating neurodegenerative diseases","volume":"20","author":"Naz","year":"2021","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"21","key":"10.1016\/j.vph.2021.106951_bb0470","article-title":"Sex differences in neurodegeneration: the role of the immune system in humans","volume":"S0006-3223","author":"Lopez-Lee","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.vph.2021.106951_bb0475","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.3390\/ijms22137150","article-title":"Network analysis identifies sex-specific gene expression changes in blood of amyotrophic lateral sclerosis patients","volume":"22","author":"Santiago","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2021.106951_bb0480","doi-asserted-by":"crossref","first-page":"101459","DOI":"10.1016\/j.arr.2021.101459","article-title":"Female Brain Health and Endocrine Research (FEMBER) consortium. Female specific risk factors for the development of Alzheimer\u2019s disease neuropathology and cognitive impairment: call for a precision medicine approach","volume":"71","author":"deh-Momoh","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2021.106951_bb0485","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-444-64123-6.00018-7","article-title":"Sex difference in Alzheimer\u2019s disease: an updated, balanced and emerging perspective on differing vulnerabilities","volume":"175","author":"Dubal","year":"2020","journal-title":"Handb. Clin. Neurol."},{"issue":"11","key":"10.1016\/j.vph.2021.106951_bb0490","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","article-title":"Alzheimer\u2019s pathogenic mechanisms and underlying sex difference","volume":"78","author":"Zhu","year":"2021","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121001233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121001233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:20:28Z","timestamp":1761528028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189121001233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":98,"alternative-id":["S1537189121001233"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2021.106951","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The close link between brain vascular pathological conditions and neurodegenerative diseases: Focus on some examples and potential treatments","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2021.106951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106951"}}